Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.
about
Chemotherapy for advanced non-small cell lung cancer in the elderly populationUse of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.Inhibitors of histone deacetylases enhance neurotoxicity of DNA damageNucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage.
P2860
Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase II randomized study comp ...... ed non-small cell lung cancer.
@ast
Phase II randomized study comp ...... ed non-small cell lung cancer.
@en
type
label
Phase II randomized study comp ...... ed non-small cell lung cancer.
@ast
Phase II randomized study comp ...... ed non-small cell lung cancer.
@en
prefLabel
Phase II randomized study comp ...... ed non-small cell lung cancer.
@ast
Phase II randomized study comp ...... ed non-small cell lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Phase II randomized study comp ...... ced non-small cell lung cancer
@en
P2093
Anthony P C Yim
Conrad Lee
Herman Wong
Karen Chak
Kwok Chi Lam
P2860
P304
P356
10.1159/000086992
P577
2005-07-13T00:00:00Z